Enclosed herewith Outcome of the Board Meeting.

Date: August 14, 2026 The Manager, Listing Department, BSE Limited, P. J. Tower, Dalal Street, Mumbai – 400 001 Scrip Code: 530825 Security ID: DAIKAFFI Sub: Outcome of the Board Meeting in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”): Dear Sir/Ma'am, The Board of Directors of the Company at its meeting held today, i.e., August 14, 2026, has, inter alia, considered and approved the following: 1. Financial Results: Pursuant to Regulation 33 of Listing Regulations, The Board considered and approved the Unaudited Financial Results for the quarter ended June 30, 2026 together with Limited Review Report thereon. Please find enclosed herewith the Un-audited Financial Result for the quarter ended June 30, 2026 together with Limited Review Report of Auditor thereon; An extract of the aforementioned results would be published in the newspaper in accordance with the Listing Regulations. The Financial Result will also be available on the website of the Company at www.daikaffil.com and also on website of BSE Ltd at www.bseindia.com. The meeting commenced at 3:00 pm and concluded at 3:45 pm. Kindly take the same on your records and acknowledge the receipt of same. Thanking You. Yours faithfully, For Daikaffil Chemicals India Limited Jay Chandu Patel Company Secretary and Compliance Officer M. No.: A73587 Independent Auditor’s Review Report on Standalone Unaudited Financial Results for the quarter ended on June 30, 2026, of Daikaffil Chemicals India Limited, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as Amended) The Board of Directors of Daikaffil Chemicals India Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results (“the Statement”) of Daikaffil Chemicals India Limited (“the Company”) for the quarter ended June 30, 2026, being submitted by the Company pursuant to the requirements of regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (as amended)” Listing Regulations”, including relevant circulars issued by the SEBI from time to time. 2. Management’s Responsibility The Statement is the responsibility of the Company’s Management and has been approved by the Board of Directors. This statement has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (Ind-AS 34) prescribed under section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion in our report on this statement of standalone unaudited financial results based on our review. 3. Auditor’s Responsibility We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statement is free of material misstatements. A review of interim financial information consists of making inquiries, primarily of persons responsible for accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards of Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. We have not performed an audit and, accordingly, we do not express an audit opinion. 4. Conclusion Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement of standalone unaudited financial results, prepared in accordance with applicable accounting standards as specified under section 133 of the Companies Act, 2013, read with rule 7 of the Companies (Accounts) Rules, 2014 and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. Other Matter Attention is drawn to the fact that the figures for the three months ended March 31, 2026, as reported in these standalone unaudited financial results, are the balancing figures between audited figures in respect of the full previous financial year and the year-to-date reviewed figures up to the third quarter of the previous financial year. For N V C & Associates LLP Chartered Accountants FRN. 106971W/ W101085 N Jayendran Partner M. No. 040441 Mumbai, Dated: August 14, 2026 UDIN: DAIKAFFIL CHEMICALS INDIA LIMITED Regd. Office : E-4, M.I.D.C., Tarapur, Dist-Palghar, Maharashtra - 401506 Tel. No.: 02525-272674 Corporate Office: 2nd Floor, A Wing, Fortune Avirahi, Jain Derasar Road, Borivali-West, Mumbai-400092, CIN: L24114MH1992PLC067309 Tel. No.: +91 22 5070 5050 Email: cs@daikaffil.com Website: www.daikaffil.com Statement of Unaudited Standalone Financial Results for the quarter ended June 30, 2026 ( All figures are Rupees in Lakhs unless otherwise Stated ) Quarter Ended Year Ended I::J.. 30.06.2026 31.03.2026 30.06.2025 31.03.2026 Particulars Unaudited Unaudited Unaudited Audited 1 |Income (a) Revenue from Operations 102.98 196.65 387.69 1,334.75 (b) Other Income 0.73 1.78 0.88 5.31 Total Income 103.71 198.43 388.57 1,340.06 2 | Expenses (a) Cost of materials consumed 113.96 122.95 619.72 978.64 (b) Ch-anges in Inventories of Finished Goods and (70.08) 2451 (434.02) (8.35) Work-in-Progress (c) Employee Benefits Expense 41.52 44.86 37.90 172.16 (d) Finance Costs 0.47 0.17 0.55 0.81 (e) Depreciation and Amortisation Expense 7.65 9.58 9.71 36.43 (f) Other Expenses 73.82 85.95 112.68 378.65 Total Expenses 167.34 288.02 346.54 1,558.34 Profit/(Loss) before Exceptional Item and Tax (1-2) (63.63) (89.59) 42.03 (218.28) 4 | Exceptional Items - - - - 5 | Profit/(Loss) before Tax (3+4) (63.63) (89.59) 42.03 (218.28) 6 | Tax Expenses/(Credit) (a) Current Tax - - - - (b) Deferred tax charge / (credit) (0.90) (0.49) (0.44) (4.21) (c) Tax Adjustment of earlier periods - - - - Total Tax Expenses (0.90) (0.49) (0.44) (4.21) 7 | Profit/ (Loss) for the Period after Taxes (5-6) (62.73) (89.10)| 42.47 (214.07) 8 | Other Comprehensive Income (net of Taxes) (a) Items that will not be reclassified to profit or loss (net of tax) 0.68 1.39 (1.79) 2.63 (b) Items that will be reclassified to profit or loss (net of tax) - = - - Total Other Comprehensive Income (net of Taxes) 0.68 1.39 (1.79) 2.63 9 | Total Comprehensive Income for the period (7+8) (62.05) (87.71) 40.68 (211.44) 10 | Paid up Equity Share Capital (Face value of Rs.10 per share - each fully paid up) 600.00 600.00 600.00 600.00 11 | Other Equity - - - 73.77 12 | Earning per share {not annualised for the quarters) (a) Basic (1.05) (1.49) 0.71 (3.57) (b) Diluted (1.05) (1.49) 0.71 (3.57) Notes: The above Standalone Financial Results, as reviewed by the Audit Committee, were approved and taken on record by the Board of Directors at its meeting held on August 14, 2026. The statutory auditors have carried out a limited review of the standalone financial results for the quarter ended June 30, 2026 and have issued their unmodified report thereon. The figures for the quarter ended March 31,2026 is the balancing figures between the audited figures in respect of the full financial year and unaudited year to date figures upto the third quarter ended December 31,2025 which were subjected to limited review. The standalone results of the Daikaffil Chemicals India Limited (the C [Showing first 8,000 characters — download PDF for full document]